Summary
Cara Therapeutics Inc
Founded in 2004
Description
Official Twitter feed for Cara Therapeutics. Our mission is to transform the way pruritus is treated to bring quality to the lives of those who suffer.
Strengths
- Cara Therapeutics Inc has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Cara Therapeutics Inc was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
Cara Therapeutics Inc's annual revenue
$25883000
Based on Kona Equity data
-
Revenue per employee
$308131
-
Variance of revenue growth
67.1
-
Annual revenue growth since founding
$1294150
-
Revenue growth rate from first known quarter to current
1378.5%
Employee Count
84 employees
-
Employee growth rate from first known quarter to current
48.6%
Executives
Mani Mohindru
Chief Financial Officer & Chief Strategy Officer
m**@caratherapeutics.comKatlyn Mcbergin
Lead Clinical Trial Associate
k**@caratherapeutics.comIsaac Adegbile
Drug Safety Operations Head
i**@caratherapeutics.comChristopher Posner
CEO
c**@caratherapeutics.comJoana Goncalves
Chief Medical Officer
j**@caratherapeutics.comJoshua Cox
Manager, Drug Safety Database
j**@caratherapeutics.comRobert Medve
Chief Medical Officer
r**@caratherapeutics.comRyan Maynard
Chief Financial Officer
r**@caratherapeutics.comAdam Russell
Alliance Manager
a**@caratherapeutics.comSamuel Brantman
Senior Medical Science Liaison
s**@caratherapeutics.comWarren Wen
Vice President
w**@caratherapeutics.comAdam Mckay
Clinical Payment Coordinator
a**@caratherapeutics.comRichard Makara
Interim Chief Financial Officer, Vice President, Head of Accounting & Controller
r**@caratherapeutics.comPatricia Goldbach
Executive Administrative Assistant
p**@caratherapeutics.comSusan Wilson
Director, Toxicology
s**@caratherapeutics.comBill Chiarelli
Senior Manager, Supply Chain
b**@caratherapeutics.comWilliam Coogan
Associate Director, Quality Assurance
w**@caratherapeutics.comEric Vandal
Senior VP, Commercial
e**@caratherapeutics.comBrenden Schultek
Vice President, Sales
b**@caratherapeutics.comVincent Fucci
Accounts Payable Accountant
v**@caratherapeutics.comFrank Giordano
Senior Director, Commercial Supply Chain
f**@caratherapeutics.comRobert Spencer
Vice President, Research & Development
r**@caratherapeutics.comRonnie Scherer
Consultant
r**@caratherapeutics.comKristine Nograles
Vice President, Clinical Development
k**@caratherapeutics.comAngela Ross
Medical Science Lakes Region Liaison
a**@caratherapeutics.comIris Francesconi
Corporate Strategy & Investor Relations Chief
i**@caratherapeutics.comCharlotte Champigny
Clinical Trial Assistant
c**@caratherapeutics.comStephen Connor
Executive Director, Chemistry Research & CMC
s**@caratherapeutics.comPhone Therapeutics
President & Chief Executive Officer
p**@caratherapeutics.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
2.35 M
-
Page views per visitor
1.0
-
Daily time
1:36
Location
Unlock unlimited leads
Similar Companies
GlycoMimetics
glycomimetics.com- Founded in 2003
- Location: Rockville, MD
- Annual Revenue: $104.0K
- Employees: 52
- GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. GlycoMimetics is a late clinical stage biotechnology company discovering and developing glycobiology based therapies for cancers...
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
Leap Therapeutics
leaptx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $1.1M
- Employees: 36
- Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...
Otonomy
otonomy.com- Founded in 2008
- Location: San Diego, CA
- Annual Revenue: $35.0K
- Employees: 51
- In 2008, Jay Lichter, Ph.D., a partner at Avalon Ventures and biotechnology industry veteran, experienced his first severe attack of vertigo. While driving, he became severely disoriented and had to pull to the side of the road. After multiple doctor v...
Galera Therapeutics, Inc.
galeratx.com- Founded in 2009
- Location: Malvern, PA
- Annual Revenue: $6.3M
- Employees: 30
- This is the home page.
Pharmazz Inc
pharmazz.com- Founded in 2010
- Location: Willowbrook, IL
- Annual Revenue: $7.2M
- Employees: 23
- Pharmazz, Inc. was founded in 2010 and it rapidly established a multi-national collaborative team with facilities and management in the US, UK and India. Company is focused on therapeutic markets with unmet clinical needs in the area o...
Key Information
- Name: Cara Therapeutics Inc
- Category: Biotechnology
- Industry: Laboratory
- SIC: 28; 283
- NAICS: 32541; 5417
See similar companies
-
By City Stamford Small Laboratory in Stamford Mid-size Laboratory in Stamford Biotechnology in Stamford Small Biotechnology in Stamford Mid-size Biotechnology in Stamford
-
By State CT Small companies in CT Biotechnology in CT Small Biotechnology in CT Mid-size Biotechnology in CT Small Laboratory in CT Mid-size Laboratory in CT
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Laboratory Small Laboratory Mid-size Laboratory Biotechnology and Laboratory
-
Firmographic data G Score of 6 Founded in 2004 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 5417 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare #Biotechnology
Frequently Asked Questions
Cara Therapeutics Inc's headquarters are located at 4 Stamford Plz. Stamford, CT 06902.
Cara Therapeutics Inc's official website is caratherapeutics.com
Cara Therapeutics Inc's annual revenue is $25.9 M.
Cara Therapeutics Inc's SIC: 28; 283
Cara Therapeutics Inc's NAICS: 32541; 5417.
Cara Therapeutics Inc has 84 employees
Cara Therapeutics Inc is in the industry of Biotechnology.
